DYNLT3 and breast carcinoma: Silence of DYNLT3 expression inhibited cell viability, migration, and invasion, and enhanced the proportion of apoptotic cells, while the proliferative, migratory and invasive abilities in DYNLT3‐overexpressed breast cancer cells were improved.